Revisiting traditional Chinese materia medica from European historical collections and perspective for current use

10.1016/j.jtcme.2021.11.001

Yusheng Jia；Mei Wang；Tinde van Andel

Chinese materia medica ； Historical CMM collections ； Traditional Chinese medicine ； Medicinal plant parts ； CMM development

Journal of Traditional and Complementary Medicine

12卷2期（2022 / 03 / 01）

206 - 216

英文

Background and aim: Chinese Materia Medica (CMM) is subject to changes over time. Investigating changes in botanical ingredients, applications, plant parts used as well as name changes over time, contribute to the understanding of the history and development of CMM. Materials and methods: This study compares four historic collections of CMM, located in Europe, compiled between 1700 and the late 19th century, with a list of contemporary CMM marketed in Europe. Results: More than 1700 specimens within these five collections. The dominant families are Fabaceae (5.3-7.2%) and Asteraceae (4.1-5.7%), while half of the medicinal parts are represented by roots or rhizomes and fruits and/or seeds. Their importance has been stable in a time span of 300 years. The proportion of animal and mineral drugs gradually decreased over time. 14 plant species appeared in all five collections. A total of 47 species are shared between the three more recent collections and the modern trade list. Among these common species, most medicinal parts remain unchanged, but for several species the used plant parts changed or new medicinal plant parts appeared. All common species have unanimously been used in ancient classical TCM formulae and/or Chinese patent medicines. Conclusions: Over more than 300 years, the main body of CMM has hardly changed, with regard to plant taxa and plant parts used. The most prominent changes are related to conservation issues of threatened species, health safety and the discovery of new pharmacological applications of well-known species. Analyzing physical specimens from historic CMM collections complements literature-based research.

1. Bing, Q,Zhang, B(2008).The botanical identification of Shancigu in Chinese ancient literature.J Systemat Evol,46(5),785-792.
2. Brand, E,Leon, C,Nesbitt, M(2017).Economic botany collections: a source of material evidence for exploring historical changes in Chinese medicinal materials.J Ethnopharmacol,200,209-227.
3. Challender, D,Waterman, C.(2017).,Geneva:CITES.
4. Chen, P,Xie, P.(1999).History and Development of Traditional Chinese Medicine.IOS Press.
5. Chen, Z,Huang, S.(2005).Materia Medica Literature.Nanjing:Dongfang University Press.
6. Chinese Pharmacopoeia Commission(2015).Pharmacopoeia of the People's Republic of China (2015 Edition).Beijing:Medical Science and Technology Press.
7. Cragg, GM,Newman, DJ(2001).Natural product drug discovery in the next millennium.Pharm Biol,39(sup1),8-17.
8. Dioscorides P, Mattioli PA, Bascarini N. Di Pedacio Dioscoride Anazarbeo Libri Cinque Della Historia, & Materia Medicinale. Venice: Nicolo de Bascarini; 1544.
9. European Medicines Evaluation Agency(2005).European Medicines Evaluation Agency. Public Statement on the Risks Associated with the Use of Herbal Products Containing Aristolochia Species. London. 2005..
10. Flora of China Editorial Committee(1994).Flora of China.Beijing:Science Press.
11. Fuchs L. De Historia Stirpium Commentarii Insignes. Basel: Officina Isingriniana; 1542.
12. Gdatc Orta, Lsd Camões(1963).Colóquios dos simples e drogas e cousas medicinais da India, Reproducão fac-similada da edicão impressa em Goa em 10 de Abril de 1563. Comemorando o quarto centenário da edicão original.Lisboa:Academia das Ciencias.
13. He, X,Fang, J,Huang, L,Wang, J,Huang, X(2015).Sophora flavescens Ait.: traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine.J Ethnopharmacol,172,10-29.
14. Heinrich, S,Wittman, TA,Ross, JV,Shepherd, CR,Challender, D,Cassey, P(2017).TRAFFIC ReportTRAFFIC Report,Selangor:.
15. Hooper D. On Chinese Medicine: Drugs of Chinese Pharmacies in Malaya. Botanic Gardens; 1929.
16. Jia, Y,Lei, L,Luo, X,Zhao, Z,Wang, M,van, Andel, T(2021).Analysis of historical changes in traditional Chinese medicine based on an Indonesian collection of Chinese materia medica from c. 1870.J Ethnopharmacol,269,113714.
17. Li, LC,Zhang, ZH,Zhou, WC(2020).Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: advances and prospects.Biomed Pharmacother,130,110641.
18. Lord, GM,Tagore, R,Cook, T,Gower, P,Pusey, CD(1999).Nephropathy caused by Chinese herbs in the UK.Lancet,354(9177),481-482.
19. Ma, X,Zheng, C,Hu, C,Rahman, K,Qin, L(2011).The genus Desmodium (Fabaceae)-traditional uses in Chinese medicine, phytochemistry and pharmacology.J Ethnopharmacol,138(2),314-332.
20. Meng, Q,Niu, Y,Niu, X,Roubin, RH,Hanrahan, JR(2009).Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine.J Ethnopharmacol,124(3),350-368.
21. Michl, J,Ingrouille, MJ,Simmonds, MS,Heinrich, M(2014).Naturally occurring aristolochic acid analogues and their toxicities.Nat Prod Rep,31(5),676-693.
22. Qiu, J(2007).Traditional medicine: a culture in the balance.Nature,448(7150),126-128.
23. Qu, L,Zou, W,Wang, Y,Wang, M(2018).European regulation model for herbal medicine: the assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.Phytomedicine,42,219-225.
24. Shibutani, S,Dong, H,Suzuki, N,Ueda, S,Miller, F,Grollman, AP(2007).Selective toxicity of aristolochic acids I and II.Drug Metab Dispos.,35(7),1217-1222.
25. Stefanaki, A,Porck, H,Grimaldi, IM(2019).Breaking the silence of the 500-year-old smiling garden of everlasting flowers: the En Tibi book herbarium.PLoS One,14(6),e0217779.
26. Stefanaki, A,Thijsse, G,Van Uffelen, GA,Eurlings, MC,Van Andel, T(2018).The En Tibi herbarium, a 16th century Italian treasure.Bot J Linn Soc,187(3),397-427.
27. van Andel, T,Barth, N(2018).Paul Hermann's ceylon herbarium (1672-1679) at Leiden, The Netherlands.Taxon,67(5),977-988.
28. Van Andel, T,Scholman, A,Beumer, M(2018).Icones Plantarum Malabaricarum: early 18th century botanical drawings of medicinal plants from colonial Ceylon.J Ethnopharmacol,222,11-20.
29. Vanherweghem, JL,Depierreux, M,Tielemans, C(1993).Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.Lancet,341(8842),387-391.
30. Verma, N(2016).Current regulatory challenges and approaches in the registration of herbal drugs in Europe.Clin Res Regul Aff,33(1),9-24.
31. Winterbottom, AE(2015).Of the China root: a case study of the early modern circulation of materia medica.Soc Hist Med,28(1),22-44.
32. Xie, Z(2008).Chinese Medicinal Varieties: Theory and Use.Beijing:People’s Medical Publishing House.
33. Zhao, Z,Guo, P,Brand, E(2018).A concise classification of bencao (materia medica).Chin Med,13(1),18.
34. Zhao, Z,Zhao, K,Brand, E(2015).Identification of ancient Chinese medicinal specimens preserved at natural history museum in London.China J Chin Mater Med,40(24),4923-4927.
35. Zhong Hua Ben Cao Edit Committee(1999).Zhong Hua Ben Cao.Shanghai:Shanghai Scientific and Technical Publishers.
36. Zhong Yao Da Ci Dian Edit Committee(2006).Zhong Yao Da Ci Dian.Shanghai:Shanghai Scientific and Technical Publishers.